PharmaCyte Biotech Inc (PMCB)

[Hotelier51]

See, Pharmacyte/Nuvilex PAYS TD2. They don't do this out of the goodness of their own hearts. They aren't employees. They aren't partners. TD2's business model is to take money for company's and perform services.

Plus we have heard very very little from them and I think nothing at all from Dr. Hoff outside of the press release 18 months ago. TD2 doesn't even handle pancreatic cancer research now.

Dr. Lohr is an original part owner of the patent dating back to 1995. This is his thing. He wasn't enticed from the outside. He has been trying and failing for 20 years on CiAB. But he's certainly willing to take money from a penny stock CEO.

Everything attached to Nuvilex/Pharmacyte, be it the product, the employees, the partners all have huge caveats.

Here is the patent from 1998. Lohr, Gunzberg and Salmons. They are all there:

Encapsulated cells producing cytochrome P450
Patent number: 6893634
Abstract: The present invention relates to capsules encapsulating cytochrome P450 producing cells and cytochrome P450 producing retroviral packaging cells. Furthermore, the present invention relates to the treatment of cancer or any other relevant disease with said capsules and to the use of said capsules for the preparation of a pharmaceutical composition for said treatment.
Type: Grant
Filed: September 24, 1998
Issued: May 17, 2005
Assignees: GSF-Forschungszentrum fur Umwelt und Gesundheit GmbH, Bavarian Nordic A/S
Inventors: Walter H. Günzburg, Peter Karle, Robert Saller, Brian Salmons, Matthias Löhr, Peter Müller